The soy isoflavone daidzein is bioconverted to 7,8,4′-trihydroxyi soflavone (7, 8, 
| BACKGROUND
Daidzin (Fig. S1 ) is the most well-studied isoflavonoid in soybeans, and is present at approximately 118.5 mg per 100 g of dry weight. [1] Hepatic metabolism of daidzein yields the compound 7,8,4′-trihydroxyisoflavone (7, 8 ,4′-THIF); [2] this compound is also found in aged Korean fermented soya paste, known as doenjang. [3] Solar UV radiation is divided into three wavelength ranges: UVA (320-400 nm), UVB (280-320 nm), and UVC (200-280 nm). UVB is absorbed into the upper dermis of the skin and has numerous detrimental effects, including sunburn and immunosuppression. UVB exposure also has long-term consequences such as skin cancer and premature skin ageing, also known as photoaging. [4, 5] Matrix metalloproteinase (MMP)-1 is the main MMP responsible for degradation of the extracellular matrix. [6, 7] Repeated exposure to UVB can increase MMP-1 expression in dermal tissue through AP-1 activation, [8] and consequently promotes skin wrinkling. [6, 9, 10] In a previous study, it was reported that the dominant negative mutant of PKCλ/ι suppressed UVB-induced AP-1 activation. [11] Additionally, other isotypes of PKC were reported to be regulators of various signalling pathways related to UVB-induced skin ageing. [12] [13] [14] 
| QUESTIONS ADDRESSED
We investigated the MMP-1 inhibitory activity of 7,8,4′-THIF, the bioconversion product of daidzein. We report for the first time that 
| EXPERIMENTAL DESIGN

| Human Skin equivalent preparation
Human skin equivalent (Neoderm-ED) was purchased from
Tegoscience (Seoul, Korea) and incubated at 37°C in an atmosphere of 5% CO 2 . After 2 weeks of air-lift, the human skin equivalent was treated with 7,8,4′-THIF (2.5, 5, or 10 μmol/L) or retinoic acid (10 μmol/L) for 1 hour as a positive control, and irradiated with UVB at 0.05 J/cm 2 once a day for 8 days. Medium was changed every 2 days during the incubation.
| Western blot analysis and zymography
Proteins were resolved by SDS-PAGE and transferred onto PVDF membranes (Millipore, Billerica, MA, USA), which were then blocked with skim milk and hybridized with specific primary antibodies. The protein bands were visualized using an ECL solution after hybridization with a horseradish peroxidase-conjugated secondary antibody.
The activity of MMP-2 was evaluated using zymography. Zymography was performed with 10% polyacrylamide gel in the presence of gelatin (0.5 mg/mL), which was used as a substrate for MMP-2.
| In vitro Kinase assay
PKCι kinase assay was performed using active recombinant PKCι enzymes following the manufacturer's instructions. Briefly, active at 30°C for 15 minutes. The radioactively labelled phosphate was measured using a scintillation counter.
| Statistical analysis
Data are expressed as the mean±standard deviation (SD). Student's ttest was used to evaluate the mean differences between groups and statistical significance. Differences were considered significant at P<.05.
| RESULTS
We tested the activity of 7,8,4′-THIF in a 3D human skin equivalent model, which has been reported to be more physiologically accurate The activity of the major transcription factor AP-1 was attenuated by 7,8,4′-THIF, as seen in Figure 1D . Additionally, the activity of the MAPK signalling pathway (the upstream signalling pathway of AP-1)
was decreased by treatment with 7,8,4′-THIF (Fig. S2 ).
The kinase array in Fig. S3 shows that PKCι may be a target protein Figure 2B , the binding between Figure 2D ). This supports the notion that 7,8,4′-THIF acts as an inhibitor of PKCι. [16] 
| CONCLUSIONS
In this study, we investigated the MMP-1 inhibitory activity of 7,8,4′-THIF, the bioconversion product of daidzein. We report for the first time that 7,8,4′-THIF decreases UVB-induced MMP-1 expression by directly inhibiting PKCι kinase activity. These results suggest that 7,8,4′-THIF could be developed as an antiskin ageing cosmeceutical agent.
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